Website URL : https://www.horn-pharma.de/

Website Title : Horn Pharmaceutical Consulting - ASMF, Active Substance Master File, US-DMF, Drug Master File, Certificate of suitability, CEP, CTA ,Clinical Trial Application, IND, Investigational New Drug Application, CTD, Common Technical Document, European MAA, Marketing Authorization Application, NDA, New Drug Application / BLA, Biologic License Application, SPCs, Summary of Product Characteristics, clinical or nonclinical study protocols and reports, clinical or nonclinical summaries and overviews, quality overall summaries, QOS, CMC-documents, regulatory strategies, Authorities, EMA, FDA, GMP, GCP, GLP, quality systems, SOPs, training, pharmaceutical, biotechnology, API ,Active Pharmaceutical Ingredient manufacturer, contract manufacturer, contract laboratory, SME, Small and Medium-sized Enterprise, medical device industry, advanced therapy industry, pre-submission, submission, pre-approval, approval, post-approval phase

Website Description : HORN Pharmaceutical Consulting provides regulatory and business advice to companies from the pharmaceutical, biotechnology and medical device industries.

Keywords Used : ASMF, Active Substance Master File, US-DMF, Drug Master File, Certificate of suitability, CEP, CTA ,Clinical Trial Application, IND, Investigational New Drug Application, CTD, Common Technical Document, European MAA, Marketing Authorization Application, NDA, New Drug Application / BLA, Biologic License Application, SPCs, Summary of Product Characteristics, clinical or nonclinical study protocols and reports, clinical or nonclinical summaries and overviews, quality overall summaries, QOS, CMC-documents, regulatory strategies, Authorities, EMA, FDA, GMP, GCP, GLP, quality systems, SOPs, training, pharmaceutical, biotechnology, API ,Active Pharmaceutical Ingredient manufacturer, contract manufacturer, contract laboratory, SME, Small and Medium-sized Enterprise, medical device industry, advanced therapy industry, pre-submission, submission, pre-approval, approval, post-approval phase